|
1.
|
|
9 p, 821.4 KB |
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma : Final Results of a Randomized Phase III Study
/
Kwak, Larry W. (Comprehensive Cancer Center, Duarte) ;
Sancho, Juan Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Cho, Seok Goo (The Catholic University of Korea, Seoul, South Korea) ;
Nakazawa, Hideyuki (Shinshu University School of Medicine, Nagano, Japan) ;
Suzumiya, Junji (Shimane University Hospital, Innovative Cancer Center/Oncology-Hematology, Izumo, Japan) ;
Tumyan, Gayane (Division of Hematology and Bone Marrow Transplantation, Blokhin Russian Cancer) ;
Kim, Jin Seok (Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea) ;
Menne, Tobias (Newcastle University, UK) ;
Mariz, José (Instituto Português de Oncología do Porto) ;
Ilyin, Nikolai (Ministry of Health of the Russian Federation) ;
Jurczak, Wojciech (Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland) ;
Lopez Martinez, Aurelio (Hospital Arnau de Vilanova (València)) ;
Samoilova, Olga (Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, Russia) ;
Zhavrid, Edvard (N. N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Belarus) ;
Yañez Ruiz, Eduardo (Universidad de la Frontera, Temuco, Chile) ;
Trneny, Marek (Charles University, Czech Republic) ;
Popplewell, Leslie (Toni Stephenson Lymphoma Cancer Center and Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA) ;
Ogura, Michinori (Kasugai Municipal Hospital, Aichi 486-8510, Japan.) ;
Kim, Wong Seog (Sungkyunkwan University School of Medicine, Seoul, South Korea) ;
Lee, Sang Joon (Celltrion. Inc, South Korea) ;
Kim, Sung Hyun (Celltrion. Inc, South Korea) ;
Ahn, Keum Young (Celltrion. Inc, South Korea) ;
Buske, Christian (University Hospital of Ulm, Germany)
Introduction: This double-blind, parallel-group, active-controlled phase III trial (NCT02260804) assessed CT-P10 and rituximab safety and efficacy in patients with previously untreated low-tumor-burden follicular lymphoma (LTBFL), including after a single switch from rituximab to CT-P10. [...]
2022 -  10.1016/j.clml.2021.08.005
Clinical Lymphoma, Myeloma & Leukemia, Vol. 22 Núm. 2 (february 2022) , p. 89-97
|
|
|
2.
|
|
9 p, 981.6 KB |
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis
/
Piñana, J.L. (Hospital Universitari i Politècnic La Fe de València) ;
Perez-Pitarch, A. (Hospital Clínico Universitario de València) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Hernandez-Boluda, J.C. (Fundación de Investigación INCLIVA) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Fox, Maria Laura (Hospital Universitari Vall d'Hebron) ;
Terol, M.J. (Fundación de Investigación INCLIVA) ;
Queraltó, Josep M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Vima, Jaume (Hospital Universitari Vall d'Hebron) ;
Valcárcel, David (Hospital Universitari Vall d'Hebron) ;
Ferriols-Lisart, R. (Hospital Clínico Universitario de València) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Solano, C. (Universitat de València) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
There is a paucity of data evaluating acute kidney injury (AKI) incidence and its relationship with the tacrolimus-sirolimus (Tac-Sir) concentrations in the setting of reduced-intensity conditioning (RIC) after allogeneic stem cell transplantation (allo-HSCT). [...]
2017 - 10.1016/j.bbmt.2017.03.035
Biology of blood and marrow transplantation, Vol. 23 Núm. 7 (july 2017) , p. 1177-1185
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
11 p, 265.1 KB |
Safinamide in clinical practice : A Spanish multicenter cohort study
/
Martí-Andrés, Gloria (Clínica Universidad de Navarra) ;
Jiménez-Bolaños, Rayco (Hospital Universitario Insular de Gran Canaria) ;
Arbelo, José Matías (Hospital Universitario Insular de Gran Canaria) ;
Pagonabarraga Mora, Javier (Institut d'Investigació Biomèdica Sant Pau) ;
Duran-Herrera, Carmen (Hospital Universitario de Badajoz) ;
Valenti-Azcarate, Rafael (Clínica Universidad de Navarra) ;
Luquin, Maria-Rosario (Clínica Universidad de Navarra) ;
Universitat Autònoma de Barcelona
Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson's Disease (PD) patients with a potential benefit on non-motor symptoms (NMS). A retrospective multicenter cohort study was conducted, in which the clinical effect of safinamide on both motor and NMS was assessed by the Clinical Global Impression of Change scale. [...]
2019 - 10.3390/brainsci9100272
Brain sciences, Vol. 9 Núm. 10 (october 2019) , p. 272
|
|
|
6.
|
|
6 p, 1.9 MB |
Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona (Catalonia, Spain) by whole genome sequencing
/
Andrés, Cristina (Centro de Investigación Biomédica en red de Enfermedades Infecciosas) ;
del Cuerpo, Margarita (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Rabella, Núria (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Piñana, Maria (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC) ;
Iglesias-Cabezas, Manuel Jesús (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC) ;
González-Sánchez, Alejandra (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC) ;
Esperalba, Juliana (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC) ;
Rando-Segura, Ariadna (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC) ;
Martín, Maria Carmen (Hospital Universitari Vall d'Hebron) ;
Fuentes, Francisco (Hospital Universitari Vall d'Hebron) ;
Rubio, Susana (Hospital Universitari Vall d'Hebron) ;
Saubi, Narcis (Centro de Investigación Biomédica en red de Enfermedades Infecciosas) ;
Pumarola Suñé, Tomàs (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC) ;
Antón, Andrés (Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC)
Influenza B viruses (FLUBV) have segmented genomes which enables the virus to evolve by segment reassortment. Since the divergence of both FLUBV lineages, B/Victoria / 2/87 (FLUBV/VIC) and B/Yamagata/16/88 (FLUBV/YAM), PB2, PB1 and HA have kept the same ancestor, while some reassortment events in the other segments have been reported worldwide. [...]
2023 - 10.1016/j.virusres.2023.199089
Virus Research, Vol. 330 (April 2023) , art. 199089
|
|
|
7.
|
|
9 p, 1.9 MB |
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
/
Guglieri-Lopez, Beatriz (Hospital Universitari Doctor Peset (València)) ;
Perez-Pitarch, Alejandro (Hospital Clínico Universitario de València) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Gimenez, Estela (Hospital Clínico Universitario de València) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Rabella, Núria (Institut d'Investigació Biomèdica Sant Pau) ;
Hernandez-Boluda, Juan Carlos (Hospital Clínico Universitario de València) ;
Fox, Maria Laura (Hospital Universitari Vall d'Hebron) ;
Valcárcel, David (Hospital Universitari Vall d'Hebron) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Ferriols-Lisart, Rafael (Hospital Clínico Universitario de València) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Solano, Carlos (Universitat de València) ;
Navarro, David (Universitat de València) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Piñana, José Luis (Instituto de Salud Carlos III) ;
Universitat Autònoma de Barcelona
The current study evaluates the clinical effect of sirolimus exposure on the occurrence of cytomegalovirus (CMV)DNAemia necessitating preemptive antiviral therapy. A total of 167 consecutive recipients of reduced-intensity conditioning (RIC)allogeneic hematopoietic stem cell transplantation (allo-HSCT)who received sirolimus- and tacrolimus-based graft-versus-host disease (GVHD)prophylaxis and whose CMV serostatus was positive for donors and/or recipients were included in this multicenter retrospective study. [...]
2019 - 10.1016/j.bbmt.2019.01.012
Biology of blood and marrow transplantation, Vol. 25 Núm. 5 (may 2019) , p. 1022-1030
|
|
|
8.
|
|
|
9.
|
|
20 p, 1.0 MB |
Feline Injection-Site Sarcoma and Other Adverse Reactions to Vaccination in Cats
/
Hartmann, Katrin (Centre for Clinical Veterinary Medicine) ;
Egberink, Herman (University of Utrecht. Department of Biomolecular Health Sciences) ;
Möstl, Karin (University of Veterinary Medicine. Department for Pathobiology) ;
Addie, Diane D (Maison Zabal) ;
Belák, Sándor (Swedish University of Agricultural Sciences. Department of Biomedical Sciences and Veterinary Public Health (BVF)) ;
Boucraut-Baralon, Corine (Scanelis Veterinary Test Laboratory) ;
Frymus, Tadeusz (Warsaw University of Life Sciences-SGGW. Department of Small Animal Diseases with Clinic) ;
Lloret, Albert (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari) ;
Hofmann-Lehmann, Regina (University of Zuich. Department of Clinical Diagnostics and Services) ;
Marsilio, Fulvio (Università degli Studi di Teramo. Faculty of Veterinary Medicine) ;
Pennisi, Maria Grazia (Università di Messina. Dipartimento di Scienze Veterinarie) ;
Tasker, Séverine (Linnaeus Veterinary) ;
Thiry, Etienne (Liège University. Department of Infectious and Parasitic Diseases) ;
Truyen, Uwe (University of Leipzig. Institute of Animal Hygiene and Veterinary Public Health) ;
Hosie, Margaret J (University of Glasgow Centre for Virus Research)
Vaccine-associated adverse events (VAAEs), including feline injection-site sarcomas (FISSs), occur only rarely but can be severe. Understanding potential VAAEs is an important part of informed owner consent for vaccination. [...]
2023 - 10.3390/v15081708
Viruses, Vol. 15 (august 2023)
|
|
|
10.
|
|
11 p, 1.5 MB |
Reliability of Upper Limb Pin-Prick Stimulation With Electroencephalography : Evoked Potentials, Spectra and Source Localization
/
Triccas, Lisa Tedesco (University of Malta) ;
Camilleri, Kenneth P. (University of Malta) ;
Tracey, Camilleri (University of Malta) ;
Mansoureh, Fahimi Hnazaee (University College London Institute of Neurology) ;
Benjamin, Wittevrongel (KU Leuven) ;
Francesca, Muscat (University of Malta) ;
Boccuni, Leonardo (Institut Germans Trias i Pujol. Institut Guttmann) ;
Dante, Mantini (KU Leuven) ;
Geert, Verheyden (KU Leuven) ;
Universitat Autònoma de Barcelona
In order for electroencephalography (EEG) with sensory stimuli measures to be used in research and neurological clinical practice, demonstration of reliability is needed. However, this is rarely examined. [...]
2022 - 10.3389/fnhum.2022.881291
Frontiers in human neuroscience, Vol. 16 (july 2022)
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
